Taxane-Based Combinations As Adjuvant Chemotherapy of Early Breast Cancer: A Meta-Analysis of Randomized TrialsSabino De Placido, Giuseppe Cancello, Diego D’Agostino et al.|Journal of Clinical Oncology|2007Cited by 413
Practical classification of triple-negative breast cancer: intratumoral heterogeneity, mechanisms of drug resistance, and novel therapiesAntonio Marra, Giuseppe Curigliano, Dario Trapani et al.|npj Breast Cancer|2020Cited by 319
Managing cancer patients during the COVID-19 pandemic: an ESMO multidisciplinary expert consensusGiuseppe Curigliano, Uwe G. Liebert, Susana Banerjee et al.|Annals of Oncology|2020Cited by 313
Antibody–drug conjugates in solid tumors: a look into novel targetsCarmen Criscitiello, Giuseppe Curigliano|Journal of Hematology & Oncology|2021Cited by 251
Tumor-infiltrating lymphocytes (TILs) in ER+/HER2− breast cancerCarmen Criscitiello, Giuseppe Curigliano, Andrea Vingiani et al.|Breast Cancer Research and Treatment|2020Cited by 102